U.S. health officials inject new uncertainty into approval process for Covid boosters

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible implications for Pfizer and Moderna.

Read the full article here

Related Articles

Open Doors

Open Doors ‘22 is a new civic collaboration that brings together the most creative minds working in health, medicine, and the life sciences.